Case Control Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Apr 7, 2020; 26(13): 1474-1489
Published online Apr 7, 2020. doi: 10.3748/wjg.v26.i13.1474
Figure 5
Figure 5 Influence of microRNA-137 on colon cancer cell resistance to oxaliplatin. A: Determined miR-137 expression in constructed drug-resistant cell lines; B: Influence of oxaliplatin (L-OHP) at different concentrations on growth inhibition of HCT116/L-OHP cells in each group after transfection; C: Effects of L-OHP at different concentrations on growth inhibition of SW480/L-OHP cells in each group after transfection; D: Comparison of apoptosis rate of drug-resistant cells among different groups after transfection and apoptosis map; E: Comparison of apoptotic protein of drug-resistant cells among different groups after transfection and apoptotic protein map. SW480/L-OHP indicates SW480 cell line with L-OHP resistance. HCT116/L-OHP indicates HCT116 cell line with resistance L-OHP resistance. aP < 0.05, bP < 0.01, eP < 0.001 for between-group comparisons. L-OHP: Oxaliplatin; miR-NC: MiR negative control; OIP5-AS1: Opa-interacting protein 5 antisense RNA 1.